{"draw":1,"recordsFiltered":13103,"recordsTotal":13103,"data":[{"__attributes":{"id":"post-row-88479","class":"post-row post-type-post post-88479 publish"},"date":" 31 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" class=\"\" alt=\"FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS - ME-6058 Containing Banned Ingredient\" loading=\"lazy\" title=\"FDA Advisory No.2024-1060\" data-caption=\"FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS - ME-6058 Containing Banned Ingredient\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1060-public-health-warning-against-the-purchase-and-use-of-cosmetic-product-meiya-matte-lipgloss-me-6058-containing-banned-ingredient\/\">FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS &#8211; ME-6058 Containing Banned Ingredient<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88459","class":"post-row post-type-post post-88459 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1013-A\" data-caption=\"FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1013-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88455","class":"post-row post-type-post post-88455 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" class=\"\" alt=\"FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1013\" data-caption=\"FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1013-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88451","class":"post-row post-type-post post-88451 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1008-A\" data-caption=\"FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1008-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-ms-miao-skin-firster-15g\/\">FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88447","class":"post-row post-type-post post-88447 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" class=\"\" alt=\"FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1008\" data-caption=\"FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1008-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-ms-miao-skin-firster-15g\/\">FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88391","class":"post-row post-type-post post-88391 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1011-A\" data-caption=\"FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1011-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88387","class":"post-row post-type-post post-88387 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" class=\"\" alt=\"FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1011\" data-caption=\"FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1011-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88383","class":"post-row post-type-post post-88383 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1010-A\" data-caption=\"FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1010-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88379","class":"post-row post-type-post post-88379 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" class=\"\" alt=\"FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1010\" data-caption=\"FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1010-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88375","class":"post-row post-type-post post-88375 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1009-A\" data-caption=\"FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1009-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88371","class":"post-row post-type-post post-88371 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" class=\"\" alt=\"FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1009\" data-caption=\"FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1009-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88367","class":"post-row post-type-post post-88367 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1007-A\" data-caption=\"FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1007-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-verapamil-hci-injection-usp-5-mg-2-5-mg-ml-2-ml\/\">FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88363","class":"post-row post-type-post post-88363 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" class=\"\" alt=\"FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1007\" data-caption=\"FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1007-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-verapamil-hci-injection-usp-5-mg-2-5-mg-ml-2-ml\/\">FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88359","class":"post-row post-type-post post-88359 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1005-A\" data-caption=\"FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1005-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88355","class":"post-row post-type-post post-88355 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" class=\"\" alt=\"FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1005\" data-caption=\"FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1005-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88350","class":"post-row post-type-post post-88350 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1019-A\" data-caption=\"FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1019-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88346","class":"post-row post-type-post post-88346 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" class=\"\" alt=\"FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1019\" data-caption=\"FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1019-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88342","class":"post-row post-type-post post-88342 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1018-A\" data-caption=\"FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1018-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88338","class":"post-row post-type-post post-88338 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" class=\"\" alt=\"FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1018\" data-caption=\"FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1018-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88334","class":"post-row post-type-post post-88334 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1016-A\" data-caption=\"FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1016-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-care-of-your-health-alcohol-pads-saturated-with-70-isopropyl-alcohol-100-pcs\/\">FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88330","class":"post-row post-type-post post-88330 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" class=\"\" alt=\"FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1016\" data-caption=\"FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1016-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-care-of-your-health-alcohol-pads-saturated-with-70-isopropyl-alcohol-100-pcs\/\">FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88325","class":"post-row post-type-post post-88325 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1015-A\" data-caption=\"FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1015-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-round-pink-coated-tablets-50s\/\">FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88321","class":"post-row post-type-post post-88321 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" class=\"\" alt=\"FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1015\" data-caption=\"FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1015-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-round-pink-coated-tablets-50s\/\">FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88317","class":"post-row post-type-post post-88317 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1014-A\" data-caption=\"FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1014-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88313","class":"post-row post-type-post post-88313 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" class=\"\" alt=\"FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1014\" data-caption=\"FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1014-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88309","class":"post-row post-type-post post-88309 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1012-A\" data-caption=\"FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1012-a-pinapayuhan-ng-food-and-drug-administration-fda-ang-publiko-laban-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88305","class":"post-row post-type-post post-88305 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" class=\"\" alt=\"FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1012\" data-caption=\"FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1012-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88254","class":"post-row post-type-post post-88254 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" class=\"\" alt=\"FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;JUDAH PREMIUM ORGANICS CASTOR OIL&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1054\" data-caption=\"FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;JUDAH PREMIUM ORGANICS CASTOR OIL&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1054-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-judah-premium-organics-castor-oil\/\">FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;JUDAH PREMIUM ORGANICS CASTOR OIL&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88252","class":"post-row post-type-post post-88252 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" class=\"\" alt=\"FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NISCE SKIN BASICS ANTI-ACNE SOAP&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1062\" data-caption=\"FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NISCE SKIN BASICS ANTI-ACNE SOAP&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1062-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-nisce-skin-basics-anti-acne-soap\/\">FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;NISCE SKIN BASICS ANTI-ACNE SOAP&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88246","class":"post-row post-type-post post-88246 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" class=\"\" alt=\"FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING MIX LOTION SPF 50&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1053\" data-caption=\"FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING MIX LOTION SPF 50&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1053-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-herolisas-whitening-mix-lotion-spf-50\/\">FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;HEROLISA&#8217;S WHITENING MIX LOTION SPF 50&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88242","class":"post-row post-type-post post-88242 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" class=\"\" alt=\"FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;V&amp;M NATURALS EMU OIL LIP SUNSCREEN - SMOOCH LIP DETOX&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1061\" data-caption=\"FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;V&amp;M NATURALS EMU OIL LIP SUNSCREEN - SMOOCH LIP DETOX&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1061-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-vm-naturals-emu-oil-lip-sunscreen-smooch-lip-detox\/\">FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;V&#038;M NATURALS EMU OIL LIP SUNSCREEN &#8211; SMOOCH LIP DETOX&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88238","class":"post-row post-type-post post-88238 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" class=\"\" alt=\"FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1052\" data-caption=\"FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1052-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-tone-up-sunscreen-spf50-pa-uva-uvb\/\">FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88237","class":"post-row post-type-post post-88237 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png\" class=\"\" alt=\"FDA Advisory No.2024-1059 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NU PORE K-BEAUTY CICA LATER SOOTHING FACIAL JELLY&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1059\" data-caption=\"FDA Advisory No.2024-1059 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NU PORE K-BEAUTY CICA LATER SOOTHING FACIAL JELLY&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1059-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1059-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-nu-pore-k-beauty-cica-later-soothing-facial-jelly\/\">FDA Advisory No.2024-1059 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;NU PORE K-BEAUTY CICA LATER SOOTHING FACIAL JELLY&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88230","class":"post-row post-type-post post-88230 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" class=\"\" alt=\"FDA Advisory No.2024-1058 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;MAKE-UP FIXER SPRAY STAR FLASH MAKEUP SPRAY&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1058\" data-caption=\"FDA Advisory No.2024-1058 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;MAKE-UP FIXER SPRAY STAR FLASH MAKEUP SPRAY&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1058-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-make-up-fixer-spray-star-flash-makeup-spray\/\">FDA Advisory No.2024-1058 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;MAKE-UP FIXER SPRAY STAR FLASH MAKEUP SPRAY&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88228","class":"post-row post-type-post post-88228 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" class=\"\" alt=\"FDA Advisory No.2024-1051 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;EYECARE ANTI-AGING CAFFEINE EYE SERUM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1058\" data-caption=\"FDA Advisory No.2024-1051 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;EYECARE ANTI-AGING CAFFEINE EYE SERUM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1058-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1051-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-eyecare-anti-aging-caffeine-eye-serum\/\">FDA Advisory No.2024-1051 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;EYECARE ANTI-AGING CAFFEINE EYE SERUM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88218","class":"post-row post-type-post post-88218 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png\" class=\"\" alt=\"FDA Advisory No.2024-1057 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;JUDAH PREMIUM ORGANICS ORGANIC SUNFLOWER OIL&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1057\" data-caption=\"FDA Advisory No.2024-1057 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;JUDAH PREMIUM ORGANICS ORGANIC SUNFLOWER OIL&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1057-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1057-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-judah-premium-organics-organic-sunflower-oil\/\">FDA Advisory No.2024-1057 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;JUDAH PREMIUM ORGANICS ORGANIC SUNFLOWER OIL&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88222","class":"post-row post-type-post post-88222 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png\" class=\"\" alt=\"FDA Advisory No.2024-1050 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA VITAMIN C CREAM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1050\" data-caption=\"FDA Advisory No.2024-1050 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA VITAMIN C CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1050-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1050-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-vitamin-c-cream\/\">FDA Advisory No.2024-1050 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA VITAMIN C CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88210","class":"post-row post-type-post post-88210 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png\" class=\"\" alt=\"FDA Advisory No.2024-1049 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA RETINOL CREAM TRIPLE RETINOL X COLLAGEN&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1049\" data-caption=\"FDA Advisory No.2024-1049 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA RETINOL CREAM TRIPLE RETINOL X COLLAGEN&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1049-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1049-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-retinol-cream-triple-retinol-x-collagen\/\">FDA Advisory No.2024-1049 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA RETINOL CREAM TRIPLE RETINOL X COLLAGEN&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88214","class":"post-row post-type-post post-88214 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png\" class=\"\" alt=\"FDA Advisory No.2024-1056 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;DANRYLL KLIDE SELF LOVE REVITALIZE &amp; ANTI- AGING SOAP&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1056\" data-caption=\"FDA Advisory No.2024-1056 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;DANRYLL KLIDE SELF LOVE REVITALIZE &amp; ANTI- AGING SOAP&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1056-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1056-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-danryll-klide-self-love-revitalize-anti-aging-soap\/\">FDA Advisory No.2024-1056 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;DANRYLL KLIDE SELF LOVE REVITALIZE &#038; ANTI- AGING SOAP&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88201","class":"post-row post-type-post post-88201 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png\" class=\"\" alt=\"FDA Advisory No.2024-1055 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA RADIANT NIACINAMIDE TONE-UP CREAM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1055\" data-caption=\"FDA Advisory No.2024-1055 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA RADIANT NIACINAMIDE TONE-UP CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1055-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1055-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-radiant-niacinamide-tone-up-cream\/\">FDA Advisory No.2024-1055 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA RADIANT NIACINAMIDE TONE-UP CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88206","class":"post-row post-type-post post-88206 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png\" class=\"\" alt=\"FDA Advisory No.2024-1048 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA VITAMIN C SERUM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1048\" data-caption=\"FDA Advisory No.2024-1048 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA VITAMIN C SERUM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1048-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1048-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-vitamin-c-serum\/\">FDA Advisory No.2024-1048 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA VITAMIN C SERUM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88202","class":"post-row post-type-post post-88202 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png\" class=\"\" alt=\"FDA Advisory No.2024-1047 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;VEGAN BEAUTY SUNSCREEN GEL SPF 50 PA ++&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1047\" data-caption=\"FDA Advisory No.2024-1047 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;VEGAN BEAUTY SUNSCREEN GEL SPF 50 PA ++&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1047-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1047-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-vegan-beauty-sunscreen-gel-spf-50-pa\/\">FDA Advisory No.2024-1047 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;VEGAN BEAUTY SUNSCREEN GEL SPF 50 PA ++&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88159","class":"post-row post-type-post post-88159 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1020-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cToothache Drops \u00bc oz\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1020-A\" data-caption=\"FDA Advisory No.2024-1020-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cToothache Drops \u00bc oz\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1020-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-toothache-drops-%c2%bc-oz\/\">FDA Advisory No.2024-1020-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cToothache Drops \u00bc oz\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88155","class":"post-row post-type-post post-88155 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png\" class=\"\" alt=\"FDA Advisory No.2024-1020 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cToothache Drops \u00bc oz\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1020\" data-caption=\"FDA Advisory No.2024-1020 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cToothache Drops \u00bc oz\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1020-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1020-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-toothache-drops-%c2%bc-oz\/\">FDA Advisory No.2024-1020 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cToothache Drops \u00bc oz\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88151","class":"post-row post-type-post post-88151 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1004-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1004-A\" data-caption=\"FDA Advisory No.2024-1004-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1004-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-upsa-sas-france-efferalgan-paracetamol-500-mg-effervescent-tablet\/\">FDA Advisory No.2024-1004-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88147","class":"post-row post-type-post post-88147 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png\" class=\"\" alt=\"FDA Advisory No.2024-1004 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1004\" data-caption=\"FDA Advisory No.2024-1004 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1004-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1004-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-upsa-sas-france-efferalgan-paracetamol-500-mg-effervescent-tablet\/\">FDA Advisory No.2024-1004 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cUPSA SAS France Efferalgan\u00ae Paracetamol 500 mg Effervescent Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88143","class":"post-row post-type-post post-88143 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1003-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1003-A\" data-caption=\"FDA Advisory No.2024-1003-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1003-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1003-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88139","class":"post-row post-type-post post-88139 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png\" class=\"\" alt=\"FDA Advisory No.2024-1003 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1003\" data-caption=\"FDA Advisory No.2024-1003 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1003-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1003-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1003 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88133","class":"post-row post-type-post post-88133 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1002-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1002-A\" data-caption=\"FDA Advisory No.2024-1002-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1002-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1002-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88129","class":"post-row post-type-post post-88129 publish"},"date":" 19 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png\" class=\"\" alt=\"FDA Advisory No.2024-1002 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1002\" data-caption=\"FDA Advisory No.2024-1002 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1002-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1002-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1002 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""}]}
